pCloud for Small Business: A European Alternative to Google Workspace and OneDrive?Featured
Cloud & Software

pCloud for Small Business: A European Alternative to Google Workspace and OneDrive?

pCloud Business offers EU data residency, access levels, activity logs, branded links and 180-day history. Where it fits for a small firm — and where it doesn't.

Editorial Team · Jul 17, 2026
Read more

Latest articles

View all →
Shopify Analytics Update: Metafields, Targets, Insights
Cloud & Software

Shopify Analytics Update: Metafields, Targets, Insights

Shopify upgraded its built-in analytics: slice reports by your own metafields, set targets on any metric, pin annotations onto charts and get automatic Insights on what's trending. What each addition does, why it kills a few spreadsheets, and where built-in analytics still hits its limits.

Daniel Roth · Jul 15, 2026
The AI Watchdogs Are Multiplying — and None of Them Are Talking to Each Other
Regulation & Policy

The AI Watchdogs Are Multiplying — and None of Them Are Talking to Each Other

A frontier lab, a national government, a central banker and a US state each moved to rein in AI within a single July week — and none was coordinating with the others. Oversight is finally arriving, but in disconnected pieces. That fragmentation is itself the story.

Daniel Roth · Jul 15, 2026
The AI Capex Squeeze: How GPU Spending Is Eating Enterprise IT Budgets
Analysis & Opinion

The AI Capex Squeeze: How GPU Spending Is Eating Enterprise IT Budgets

Corporate IT budgets barely grow year to year. So every dollar companies pour into scarce GPUs, AI servers and memory is a dollar pulled away from legacy software, licenses and mainframes. IBM's ~25% one-day crash is the clearest sign yet that the AI boom can hurt incumbent IT vendors before a model writes a single line of code.

Daniel Roth · Jul 15, 2026
AI-Designed Antibodies Move From Demo to the Pharma Supply Chain
AI & Enterprise

AI-Designed Antibodies Move From Demo to the Pharma Supply Chain

AI models that design proteins and antibodies are compressing drug discovery's hardest step — and big pharma is paying to license them. Chai Discovery's $400M raise and its Pfizer, Lilly and Novartis deals show AI moving into the drug industry's real supply chain. But the clinical last mile still runs at old-world odds.

Daniel Roth · Jul 15, 2026
The Grid Wall: Why States Are Freezing AI Data Centers
Chips & Infrastructure

The Grid Wall: Why States Are Freezing AI Data Centers

The constraint on the AI buildout has shifted from chips to power. Aging grids can't absorb gigawatt-scale loads landing all at once — so New York just became the first US state to pause new data centers over 50 MW, and hyperscalers are pivoting to their own dedicated generation.

Daniel Roth · Jul 15, 2026
Rumor Watch: Claude Opus 5 May Be Imminent — and Fable 5's Subscription Days Could Be Numbered
Analysis & Opinion

Rumor Watch: Claude Opus 5 May Be Imminent — and Fable 5's Subscription Days Could Be Numbered

Unconfirmed chatter suggests Anthropic is close to launching Claude Opus 5, possibly within a two-week window, while a separate rumor says Fable 5 may stop being included in subscriptions around July 19. None of it is confirmed — here's how to read the speculation without overreacting to it.

Daniel Roth · Jul 14, 2026